● Recruiting

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Condition: Metastatic Castration-Resistant Prostate Cancer · Sponsor: Pfizer

PhasePhase 3

Planned participants900

Who can joinMale, 18 Years to no upper limit

Healthy volunteersNo

About this study

This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC who are ARSi or abiraterone naïve.

This description comes directly from the study's public registry record.

Talk to the study team

Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com

Always discuss trial participation with your own doctor first.

Locations (240)

Ironwood Cancer & Research Centers	Chandler, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Gilbert, Arizona, United States	Recruiting
Palo Verde Hematology Oncology	Glendale, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Glendale, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Goodyear, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Mesa, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Mesa, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Phoenix, Arizona, United States	Recruiting
Ironwood Cancer & Research Centers	Scottsdale, Arizona, United States	Recruiting
Highlands Oncology	Fayetteville, Arkansas, United States	Recruiting
Arkansas Urology - Little Rock	Little Rock, Arkansas, United States	Recruiting
Highlands Oncology	Rogers, Arkansas, United States	Recruiting

+ 228 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06629779